Unrestrained cancer immunity ignites atherosclerosis

Abstract

Researchers map the expression of immune checkpoints and cell interactions within human atherosclerotic plaques, and the influence of relevant comorbidities such as dyslipidemia and diabetes. The findings shed light on the potential mechanisms behind the increased risk of cardiovascular events after treatment with immune checkpoint inhibitors.